Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,021.90
1,126.07
812.03
942.16
1,078.45
1,020.76
732.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,021.90
1,126.07
812.03
942.16
1,078.45
1,020.76
732.04
Raw Material Cost
214.24
252.23
201.74
194.81
162.58
244.91
165.52
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.50
0.76
0.64
1.66
1.09
0.51
0.00
Selling and Distribution Expenses
498.24
567.76
418.72
509.59
590.83
506.12
408.01
Other Expenses
1.84
2.85
6.14
3.74
3.67
1.98
5.32
Total Expenditure (Excl Depreciation)
731.42
849.24
682.46
743.42
791.17
771.32
626.73
Operating Profit (PBDIT) excl Other Income
290.5
276.8
129.60000000000002
198.70000000000002
287.3
249.4
105.3
Other Income
13.82
22.57
12.74
19.03
27.41
19.25
53.68
Operating Profit (PBDIT)
314.61
309.31
157.69
231.70
324.54
278.48
177.96
Interest
0.50
0.76
0.64
1.66
1.09
0.51
0.00
Exceptional Items
1.61
0.83
-8.13
2.80
-1.62
-0.38
3.64
Gross Profit (PBDT)
807.67
873.84
610.29
747.35
915.87
775.85
566.52
Depreciation
23.86
23.86
26.75
26.75
23.89
23.89
19.06
Profit Before Tax
291.86
285.51
122.17
206.08
297.93
253.70
162.53
Tax
41.39
38.07
13.00
28.34
38.74
36.94
13.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
248.76
246.33
108.57
176.55
257.57
216.82
148.68
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
248.76
246.33
108.57
176.55
257.57
216.82
148.68
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.66
1.11
0.34
1.12
1.57
-0.08
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
250.41
247.44
108.91
177.67
259.13
216.73
148.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,231.63
3,648.87
3,400.58
3,248.24
3,066.39
3,311.52
3,072.53
Earnings per share (EPS)
0.44
0.43
0.19
0.31
0.45
0.38
0.26
Diluted Earnings per share
0.44
0.43
0.19
0.31
0.45
0.38
0.26
Operating Profit Margin (Excl OI)
27.1%
23.34%
14.56%
19.73%
25.34%
23.05%
14.37%
Gross Profit Margin
30.9%
27.47%
18.34%
24.71%
29.84%
27.19%
24.81%
PAT Margin
24.34%
21.88%
13.37%
18.74%
23.88%
21.24%
20.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -5.24% vs 8.16% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -3.36% vs 16.29% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 1.25% vs 18.08% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -54.55% vs 266.67% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Henan Lingrui Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,021.90
0
1,021.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,021.90
0
1,021.90
Raw Material Cost
214.24
0
214.24
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.50
0
0.50
Selling and Distribution Expenses
498.24
0
498.24
Other Expenses
1.84
0.00
1.84
Total Expenditure (Excl Depreciation)
731.42
0
731.42
Operating Profit (PBDIT) excl Other Income
290.48
0.00
290.48
Other Income
13.82
0
13.82
Operating Profit (PBDIT)
314.61
0
314.61
Interest
0.50
0
0.50
Exceptional Items
1.61
0
1.61
Gross Profit (PBDT)
807.67
0
807.67
Depreciation
23.86
0
23.86
Profit Before Tax
291.86
0
291.86
Tax
41.39
0
41.39
Provisions and contingencies
0
0
0.00
Profit After Tax
248.76
0
248.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
248.76
0
248.76
Share in Profit of Associates
0
0
0.00
Minority Interest
1.66
0
1.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
250.41
0
250.41
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,231.63
0
3,231.63
Earnings per share (EPS)
0.44
0
0.44
Diluted Earnings per share
0.44
0
0.44
Operating Profit Margin (Excl OI)
27.10%
0%
0.00
27.10%
Gross Profit Margin
30.90%
0%
0.00
30.90%
PAT Margin
24.34%
0%
0.00
24.34%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 102.19 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -9.25% vs 38.68% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -5.24% vs 8.16% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 25.04 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 1.21% vs 127.18% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -3.36% vs 16.29% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.08 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 4.92% vs 97.72% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 1.25% vs 18.08% in Jun 2025
Quarterly - Interest
Interest 0.05 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -37.50% vs 33.33% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -54.55% vs 266.67% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.10%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
